1. Decreased initial compound muscle action potential amplitudes in myasthenia gravis. Issue 5 (22nd August 2022) Authors: Kojima, Yuta; Shibuya, Kazumoto; Uzawa, Akiyuki; Kano, Hiroki; Nakamura, Keigo; Yasuda, Manato; Suzuki, Yo‐ichi; Tsuneyama, Atsuko; Suichi, Tomoki; Ozawa, Yukiko; Misawa, Sonoko; Noto, Yu‐ichi; Mizuno, Toshiki; Kuwabara, Satoshi Journal: Neurology and clinical neuroscience Issue: Volume 10:Issue 5(2022) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dispersion of mean consecutive differences in single‐fiber electromyography increases diagnostic sensitivity for myasthenia gravis. Issue 6 (31st March 2021) Authors: Kojima, Yuta; Shibuya, Kazumoto; Uzawa, Akiyuki; Kano, Hiroki; Nakamura, Keigo; Yasuda, Manato; Suzuki, Yo‐ichi; Tsuneyama, Atsuko; Suichi, Tomoki; Ozawa, Yukiko; Misawa, Sonoko; Noto, Yu‐ichi; Mizuno, Toshiki; Kuwabara, Satoshi Journal: Muscle & nerve Issue: Volume 63:Issue 6(2021) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High mobility group box 1 is involved in the pathogenesis of passive transfer myasthenia gravis model. Issue 9 (9th June 2021) Authors: Maimaitiming, Bibinu; Uzawa, Akiyuki; Ozawa, Yukiko; Yasuda, Manato; Kojima, Yuta; Kanai, Tetsuya; Kuwabara, Satoshi Journal: NeuroReport Issue: Volume 32:Issue 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis. (26th November 2021) Authors: Yasuda, Manato; Uzawa, Akiyuki; Ozawa, Yukiko; Kojima, Yuta; Onishi, Yosuke; Akamine, Hiroyuki; Kuwabara, Satoshi Journal: Scandinavian journal of immunology Issue: Volume 95:Number 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term prognosis of Japanese Lambert–Eaton myasthenic syndrome patients with or without small‐cell lung carcinoma. Issue 2 (20th April 2020) Authors: Kojima, Yuta; Uzawa, Akiyuki; Shibuya, Kazumoto; Yasuda, Manato; Ozawa, Yukiko; Oda, Fumiko; Shiraishi, Hirokazu; Motomura, Masakatsu; Kuwabara, Satoshi Journal: Clinical & experimental neuroimmunology Issue: Volume 11:Issue 2(2020) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Marked neurological and immunological improvement in refractory eosinophilic granulomatous polyangiitis after treatment with mepolizumab, an anti‐interleukin‐5 antibody: A case report. Issue 3 (11th April 2020) Authors: Yasuda, Manato; Sugiyama, Atsuhiko; Suichi, Tomoki; Misawa, Sonoko; Kuwabara, Satoshi Journal: Clinical & experimental neuroimmunology Issue: Volume 11:Issue 3(2020) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Propagation of Diffusion-Weighted MRI Abnormalities in the Preclinical Stage of Sporadic Creutzfeldt-Jakob Disease. (18th October 2022) Authors: Yasuda, Manato; Sugiyama, Atsuhiko; Hokkoku, Hideharu; Suichi, Tomoki; Ito, Kimiko; Satoh, Katsuya; Kitamoto, Tetsuyuki; Kuwabara, Satoshi Journal: Neurology Issue: Volume 99:Number 16(2022) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome. Issue 9 (25th March 2021) Authors: Kojima, Yuta; Uzawa, Akiyuki; Ozawa, Yukiko; Yasuda, Manato; Onishi, Yosuke; Akamine, Hiroyuki; Kawaguchi, Naoki; Himuro, Keiichi; Noto, Yu-ichi; Mizuno, Toshiki; Kuwabara, Satoshi Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 92:Issue 9(2021) Page Start: 963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Issue 5 (May 2023) Authors: Bril, Vera; Drużdż, Artur; Grosskreutz, Julian; Habib, Ali A; Mantegazza, Renato; Sacconi, Sabrina; Utsugisawa, Kimiaki; Vissing, John; Vu, Tuan; Boehnlein, Marion; Bozorg, Ali; Gayfieva, Maryam; Greve, Bernhard; Woltering, Franz; Kaminski, Henry J; Genge, Angela; Massie, Rami; Berube, Maxime; Br... Journal: Lancet neurology Issue: Volume 22:Issue 5(2023) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleeker, Jan;... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗